贝拉塔cept抑制了B细胞子集的所有反应反应
Chethan Ashokkumar1, Robert Townsend2, Mustimbo Roberts2
1Plexision, Pittsburgh, PA, United States.
Human immunology
|December 11, 2025
概括
贝拉塔cept在治疗度下有效抑制B细胞的全反应,解释了移植患者减少的捐赠者特异性抗体 (DSA) 形成. 这项研究量化了belatacept的数量.
科学领域:
- 免疫学 免疫学 免疫学
- 移植医学 移植医学
背景情况:
- 在移植接受者 (KT) 中,贝拉塔塞普治疗与较低的新生捐赠者特异性抗HLA抗体 (DSA) 发生率有关.
- 试验室研究表明,贝拉塔塞普的半最大有效度 (EC50) 与治疗度最低值 (C0) 之间存在相关性.
研究的目的:
- 调查贝拉塔塞普对B细胞抗原呈现和全响应的抑制作用.
- 为了确定这些效应是否发生在已知的治疗低谷度 (C0) 时.
主要方法:
- 从健康成年人获得的外围血液白细胞 (PBL) 用HLA不匹配的PBL或异抗原溶解酸培养.
- 增加了贝拉塔塞普特度的增加,并计算了EC50值.
- 用流式细胞计量分析了B细胞子集和全响应.
主要成果:
- 贝拉塔塞普在剂量取决的方式显著降低了全活性CD154+B细胞及其子集.
- 平均EC50值在B细胞子集中有所不同,同型切换记忆B细胞的抗性最高.
- 贝拉塔塞普没有影响B细胞抗原呈现.
结论:
- 贝拉塔塞普特在C0水平低于10μg/ml时显示出对B细胞全反应的免疫抑制活性.
- 这种B细胞抑制机制有助于在接受贝拉塔塞普治疗的移植患者中观察到DSA形成的减少.
相关概念视频
B Cell Activation and Differentiation
15.8K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
15.8K
Cell-mediated Immune Responses
83.3K
Overview
83.3K
Special Features of Adaptive Immunity
2.8K
The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
2.8K
T Cell Types and Functions
2.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.1K
Cells of the Adaptive Immune Response
8.4K
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
8.4K
T Cell Activation and Clonal Selection
14.6K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
14.6K


